Company / Capital Expenditures
BIOMERICA INC Capital Expenditures History
FY2016-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$51.0K
FY2024
5-year range
$51.0K / $64.0K
FY2020-FY2024
Trend
+0.0%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Capital Expenditures has fluctuated over the past 9 years, ranging from $51,000 in FY2024 to $135,856 in FY2020.
Based on SEC 10-K filings.
$51,000 in FY2024 with a 5-year CAGR of -12.8%.
Declined from $64,000 to $51,000 over the past 2 years.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- -3.6%
- 5-Year CAGR
- -12.8%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -12.8%, indicating a declining trend.
- In FY2024, capital expenditures increased 0.0% year-over-year.
- Peak capital expenditures was recorded in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -6.26 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | $51.0K | +0.0% |
| FY2023 | $51.0K | -20.3% |
| FY2022 | $64.0K | +12.3% |
| FY2021 | $57.0K | -58.0% |
| FY2020 | $135.9K | +34.3% |
| FY2019 | $101.1K | +0.0% |
| FY2018 | $101.1K | -22.4% |
| FY2017 | $130.3K | +35.7% |
| FY2016 | $96.1K | +4.9% |
As of FY2024 · SEC Form 10-K · Last checked Jun 22, 2026